Induction paclitaxel and carboplatin for patients with head and neck carcinoma: Analysis of 62 patients treated between 1994 and 1999

Cancer

Volumn 91, Issue 5, 2001, Pages 940-948

  Dunphy, Frank R ^a   Dunleavy, Teresa L ^a   Harrison, Bruce R ^a   Trinkaus, Kathryn M ^b   Kim, Han J ^c   Stack Jr , Brendan C ^a,e   Needles, Burton ^d   Boyd, James H ^a,f  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY   (United States)

^d ST JOHN S MERCY MEDICAL CENTER   (United States)

^e PENNSYLVANIA STATE UNIVERSITY   (United States)

^f NONE   (United States)

Author keywords

Advanced Stage Ill IV; Carboplatin; Chemotherapy; Head and neck carcinoma; Induction; Organ preservation; Paclitaxel; Preoperative

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PROGNOSIS; TREATMENT OUTCOME;

EID: 0035281542     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010301)91:5<940::AID-CNCR1083>3.0.CO;2-A     Document Type: Article

References (25)

1. Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx, or hypopharynx: Concluding report of an RTOG randomized trial on 638 patients
2. Combination of radiotherapy and surgery in the treatment of head and neck cancers
3. Patterns of spread of distant metastases in head and neck cancer
4. Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-fluorouracil
5. New approaches to the management of head and neck cancer: The role of chemotherapy
6. A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck
7. Cisplatinum induction chemotherapy in the multi-modality initial treatment of advanced Stage IV carcinoma of the head and neck
8. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharyrnx carcinoma
9. Tumors of the nasal cavity and paranasal sinuses, nasopharynx, oral cavity, and oropharynx
10. Head and neck cancer
11. Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer
12. Paclitaxel, carboplatin, and long-term continuous 5-fluorouracil infusion in the treatment of upper aerodigestive malignancies: Preliminary results of phase II trial
13. Phase II study of paclitaxel (P) twice a week as a radiosensitizer, after paclitaxel-carboplatin (C) induction in stage III-IV head and neck carcinoma
14. Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: A phase I/II trial
15. Nonparametric estimation from incomplete observations
16. Statistical aspects of the analysis of data from retrospective studies of disease
17. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples
18. A phase I report of paclitaxel dose escalation combined with a fixed dose of carboplatin in the treatment of head and neck carcinoma
19. Paclitaxel and carboplatin in head and neck cancer. Taxol Worldwide Investigators Meeting, Puerto Rico, March 12-16
20. An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck
21. Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin
22. An intensive, five course, alternating combination chemotherapy induction regimen used in patients with advanced, unresectable head and neck cancer
23. Analysis of complete responders after initial treatment with chemotherapy in head and neck cancer
24. Induction chemotherapy in advanced head and neck cancer. A Radiation Therapy Oncology Group study